Recently, research has indicated that microbiota originating from either IBD patients or mice can decrease the expression of YTHDC1 in macrophages situated in the intestines, consequently expediting the development of IBD in animal models [93]. The gene discussed is YTHDC1; the disease is irritable bowel syndrome.